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A b s t r a c t  
The purpose of this research was to mask the intensely bitter taste of metoclopramide HCl by 
complexation with glycerol monostearate. Drug- glycerol monostearate complex was 
prepared by melt granulation technique in the ratio of 1:1, 1:2, 1:3,1:4. The optimum drug: 
glycerol monostearate ratio required for complexation was determined. The drug: glycerol 
monostearate complex were evaluated for the drug content, in-vivo, in-vitro taste evaluation 
study. The complex was characterized by FTIR, differential scanning calorimetry. The taste 
evaluation depicted the successful taste masking of  metoclopramide HCl with drug: glycerol 
monostearate 1:4 ratio. 
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Introduction 
Majority of the drugs have a natural bitter taste that can create a 
burning feeling in the throat or in the mouth. In particular, a bitter 
taste can decrease the patient compliance and thus reducing an 
effective pharmacotherapy. In order to achieve an acceptable 
palatability, the addition of flavors or sweeteners is limited and 
may not be efficient enough to mask the taste buds of drugs and 
requires the use of technological processes [1, 2]. Recent years 
have seen a tremendous progress in the technique of masking the 
unacceptable taste of an orally administered pharmaceuticals, 
such as filling in capsules [3], coating with water in soluble 
polymers or pH dependent water soluble polymer, adsorption on 
ion-exchange resin (IER), micro encapsulation with various 
polymers, complexing with cyclodextrin [4], viscosity modifications 
[5] and melt granulation [6] have been described.  
Metoclopramide HCl is an intensely bitter drug, highly soluble in 
water soluble and is rapidly absorb from oral administration. It has 
a short biological half life 5-6 hr [7].  
Metoclopramide hydrochloride is recommended in dose of 10 to 
15 mg four times a day [8]. Metoclopramide HCl is a 
gastrointestinal stimulant used to treat gastro esophageal reflux, 
erosions or ulcers of esophagus [9], nausea, vomiting, heartburn, 
prolonged fullness after meals and loss of appetite in patients with 
diabetes [10]. The major problem occurs with this is its bitterness. 
Taste masking with lipophilic vehicles like lipids and lecithins: Oils, 
surfactants, polyalcohols, and lipids effectively increase the 
viscosity in the mouth and coat the taste buds, and therefore they 
are potential taste masking agents. Melt granulation is a process 
by which pharmaceutical powders are efficiently agglomerated by 
the use of a binder which can be a molten liquid or a solid that 
melts during the process [11]. Melt granulation has been 
successfully applied to develop sustained release formulations, 
taste masked formulations with lipophillic melting binders, such as 
glycerol monostearate, a combination of a hydrophobic materials, 
a starch derivative and stearic acid among others [12-15]. The 
objective of present work is to explore the utility of glycerol 
monostearate in the masking bitter taste of Metoclopramide HCl 
by novel melt granulation technique. 
Materials and methods  
Metoclopramide HCl was obtained from Aanjneya Biotech Ltd., 
Mumbai, India, Glycerol monostearate was a gift from Alpha 
Chemicals, Panvel, India, Kyron T-314 was a gift from Corel 
Pharmachem, Ahemdabad, Crosscarmellose sodium, 
Crosprovidone, Pearlitol SD 200 was a gift from Signet 
Chemicals, Mumbai, Tween 80 and Aerosol was purchase from 
Modern Scientific, Nasik, Aspartame and Magnesium stearate 
was purchase from SD Fine Chemicals, Mumbai, India. 
Methods 
Melt Granulation 
The required quantity of glycerol monostearate was weighed. It 
was melted in porcelain dish at 50-60ĈC for 5 min and the tween 
80 was added to the melted glycerol monostearate. Finally, a 
mixture of metoclopramide HCl and superdisintegrants was added 
to the molten mixture, which was then allowed to cool. Solidified 
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mass was crushed in mortar and passed through a 16 mesh sieve 
and thus granules were prepared.  
 
Determination of Threshold Bitterness 
Pure drug was subjected to sensory evaluation by the panel of six 
healthy volunteers using time intensity method. The bitter taste 
threshold value of metoclopramide HCl was determined based on 
the bitter taste recognized by six volunteers (four males and two 
females). A series of metoclopramide HCl aqueous solutions were 
prepared at different concentrations as standard solutions, i.e. 10, 
20, 30, 40, 50  øg/ml respectively. From standard solution 1 ml of 
each was placed on the center of the tongue, it was retained in 
the mouth for 15 seconds and then the mouth was thoroughly 
rinsed with distilled water. The threshold value was 
correspondingly selected from the different metoclopramide HCl 
concentrations as the lowest concentration that had a bitter taste. 
Characterization of Complex 
FTIR Spectroscopy 
The IR spectrums of pure drug, glycerol monostearate, granules 
which are prepared by melt granulation method were recorded in 
the stretching frequency range 400-4000 cm-1. The samples were 
prepared by KBr press pellet technique. 
 
Differential Scanning Calorimetry 
The DSC thermogram of pure drug, glycerol monostearate, 
granules which are prepared by melt granulation method were 
recorded. The thermal analysis was performed in a nitrogen 
atmosphere at a heating rate of 10ĈC per minute over a 
temperature range of 40ĈC to 250ĈC. 
 
Drug Content 
Drug content was determined by dissolving the melt granules 
equivalent to 10 mg  of  metoclopramide HCl in 100 ml of distilled 
water and analyzing sample after appropriate dilution by UV-
Visible Spectrophotometer at λmax 272 nm using distilled water 
as a blank. The results are shown in Table 1.  
 
In-vitro Taste Evaluation 
 Complex containing about 10 mg metoclopramide HCl were put 
into a test tube containing 10 ml of pH 6.8. The mixture was 
immediately vibrated for 15 seconds and then filtered. The clear 
solution was analyzed in a spectrophotometer at λmax 272 nm to 
determine the drug concentration in pH 6.8 after the appropriate 
dilutions, which was then compared with the threshold value. The 
calibration curve between absorbance (A) and concentration (C) 
was A = 0.0676 C + 0.0123 (r = 0.9996, n = 5) which was used for 
determination of concentration. Drug concentrations of binary 
systems were determined spectrophotometrically and were 
compared with the threshold bitterness and it was found to be 
below the threshold value of bitterness i.e 50µg/ml. 
 
In-vivo Taste Evaluation  
Gustatory sensation test was carried out by panel of human 
volunteers. Six healthy human volunteers, of either sex, in the age 
group of 22ă25 years were selected for the study. Granules 
equivalent to 10 mg of metoclopramide HCl were dispersed in 
10ml of distilled water for 15 seconds. Immediately after 
preparation, each volunteer kept about 1 ml of the dispersion in 
the mouth for 30 seconds. After expectoration, bitterness level 
was recorded. A numerical scale was used with the following 
values: 0 =Tasteless, 0.5=Very slightly bitter, 1=slightly bitter, 
1.5=Slight to moderate bitter, 2=moderately bitter, 2.5=Moderate 
to strong bitter, 3=strongly bitter, 3+ =Very strong. 
Results and Discussion 
Characterization of complex 
Fourier Transform Infra-Red Studies 
The characterization complex was carried out by Fourier 
Transform Infra-Red Study. The IR spectrum of pure drug, 
glycerol monostearate and its ratio of complex i.e. 1:4   (as shown 
in Figure No. 1-3) and from the graph of IR spectra some peaks of 
glycerol monostearate overlap the peaks of metoclopramide HCl 
and hence, broaden of intensity of peak as compared to pure 
drug, indicating formation of complex. 
 
Differential Scanning Calorimetric study 
The DSC thermograms of pure drug, Glycerol monostearate its 
ratio of complex i.e. 1:4 are shown in Figure 4-6 and Table 2. In 
complex, the Metoclopramide HCl with Glycerol monostearate, 
the endothermic peak of Metoclopramide HCl was completely 
diminished and endothermic peak of Glycerol monostearate is 
shifted towords lower side 56.24ĈC, representing complete 
possible complexation. The efficiency of glycerol monostearate 
was tested for the purpose of taste masking with the possible 
method of melt granulation. Taste masking by melt granulation is 
achieved by decreasing the surface area of the drug by increasing 
its particle size. In-vitro taste evaluation study was carried out and 
compared with that of threshold bitterness value. Tastes of all 
complexes were assessed by panel of six human volunteers by 
time intensity method which revealed the actual taste sensation of 
complexes with drug. Complex of glycerol monostearate showed 
the acceptable taste at the drug: glycerol monostearate ratio of 
1:4 for granules prepared by melt granulation technique.  
Prepared granules were evaluated for in-vitro drug release with 
reference to threshold bitterness concentration of 50øg/ml at the 
end of 15 seconds. The physical mixture of drug and glycerol 
monostearate in the ratio of 1:4 showed 44.12μ0.06 øg/ml drug 
concentration, whereas the melt granules of drug and glycerol 
monostearate in the ratio of 1:4 showed 41.40μ1.15 øg/ml 
compared with threshold bitterness value 50øg/ml. Hence from 
the results, the ratio of melt granules of drug and glycerol 
monosterate showed less threshold bitterness value as compared 
with physical mixture of drug and glycerol monostearate.  
In-vivo evaluation of bitterness score of binary systems containing 
metoclopramide HCl and glycerol monostearate was carried out 
by six human volunteers using time intensity method which are 
shown in Table 3. 
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Conclusion 
From the above results, it can be concluded that, complete taste 
masking of bitter metoclopramide HCl is achieved by granulating 
drug with glycerol monostearate by novel melt granulation 
technique. The efficiency of glycerol monostearate was tested for 
the purpose of taste masking with the possible method of melt 
granulation. Taste masking by melt granulation is achieved by 
decreasing the surface area of the drug by increasing its particle 
size. Polymers that serve as binders and taste-masking agents 
may be incorporated, which reduce the perception of taste. 
List of abbreviations 
  IER  -  Ion-Exchange Resin 
  GMS- Glycerol monostearate 
  HCl  - Hydrochloric acid   
   DSC - Differential scanning calorimetry 
  FTIR- Fourier transform infrared spectroscopy 
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Table 1 Drug Content and in-vitro Taste Evaluation of Complex of Drug:GMS 
Sr. No. Drug: GMS ratio % drug content Drug concentration (µg/ml)
1 1:1 98.30 47.14±1.34 
2 1:2 99.46 44.19±1.20 
3 1:3 99.70 43.97±1.32 
4 1:4 101.20 41.40±1.15 
               Mean_S.D.  (n_3).  
 
Table 2 Thermal Transition and Enthalpy Values of Metoclopramide HCl, Glycerol 
monostearate and Melt Complex 
Sr.No. Chemical DSC Thermal Transition (°C) Enthalpy (J/g)
1. Metoclopramide HCl 177.38 (-) 204.37 
2. Glycerol monostearate 60.11 (-) 127.21 
3. Melt Complex 
(A) Metoclopramide HCl  
(B) Glycerol monostearate 
                   
                 (A)     - 
(B) 56.24 
   
  (A) (-)     - 
(B) (-) 89.11 
 
Table 3 Results of Bitterness Score of pure drug and Melt complex of Metoclopramide HCl 
and Glycerol monostearate 
Volunteer 1 2 3 4 5 6 
Pure drug 3+ 3+ 3+ 3+ 3+ 3+ 
Drug:GMS ratio 1:1 2.5 2.5 3 2.5 2.5 2.5 
Drug:GMS ratio 1:2 2 2 2.5 2 2 2 
Drug:GMS ratio 1:3 1.5 1.5 1 1.5 1.5 1 
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Figure 1 FTIR Spectra of Metoclopramide hydrochloride 
 
Figure 2 FT-IR Spectra of Glycerol monostearate 
 
Figure 3 FT-IR Spectra of Melt Complex  
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Figure 4 DSC Thermogram of Metoclopramide HCl 
 
Figure 5 DSC Thermogram of Glycerol monostearate 
 
Figure 6 DSC Thermogram of Melt Complex 
 
